Related by context. All words. (Click for frequent words.) 76 Prolongs Survival 74 Advanced Melanoma 73 Improves Survival 73 Anthracycline 73 Patients Receiving 72 Antiangiogenic 72 Metastatic Colorectal Cancer 72 Tyrosine Kinase Inhibitor 72 Adjuvant Chemotherapy 71 Combination Treatment 71 Hormone Refractory Prostate Cancer 71 Anti Tumor 71 Meets Primary Endpoint 71 Improves Outcomes 71 Previously Treated 71 Adjuvant Therapy 71 Disease Modifying 71 Pulmonary Arterial Hypertension 71 Fungal Infections 71 Diabetic Neuropathy 71 Improved Survival 70 Combination Therapy 70 Proven Effective 70 Treating Chronic 70 Lung Cancer Drug 70 Phase 2b Trial 70 Well Tolerated 70 Renal Cell Carcinoma 70 Investigational Compound 70 Single Dose 70 Advanced Prostate Cancer 70 Antitumor Activity 70 Drug Shows Promise 70 Previously Untreated 70 Phase 2b Clinical Trial 70 Patients Treated With 70 Protease Inhibitor 70 Adjuvant Treatment 69 Paraplatin ® 69 Anticancer Drug 69 Initiates Clinical Trial 69 Allogeneic 69 Chemoradiation 69 Clinical Trial Results 69 Drug Candidate 69 Lupus Drug 69 RNAi Therapeutic 69 Adjunctive Therapy 69 Pegylated Interferon 69 Cytotoxic 69 Immune Responses 69 Novel Antibiotic 69 Is Well Tolerated 69 HER2 Positive 69 Receives Orphan Drug Designation 69 Phase IIb Trial 69 Seasonal Influenza Vaccine 69 Survival Benefit 69 Shows Promise Against 69 Allergic Rhinitis 69 Lung Cancer Patients 69 Investigational Treatment 69 Demonstrates Significant 69 Newly Diagnosed Multiple Myeloma 69 Completes Patient Enrollment 69 Prostate Cancer Vaccine 69 Tumor Targeting 69 Autoimmune Disease 69 Commonly Used 69 Rheumatoid Arthritis Patients 69 Metastatic Prostate Cancer 69 Antifungal 69 Bevacizumab 69 Contrast Agents 69 Novel Oral 68 Kinase Inhibitor 68 Mouse Model 68 Chemotherapeutic Agents 68 Genes Involved 68 Orally Active 68 Shows Efficacy 68 Pemetrexed 68 Advanced Solid Tumors 68 Investigational Agent 68 Dendritic Cells 68 Neoadjuvant Chemotherapy 68 Confirms Efficacy 68 Monotherapy 68 HER2 Positive Breast Cancer 68 Skeletal Muscle 68 Unfractionated Heparin 68 Monoclonal Antibody 68 Fondaparinux 68 Hormone Receptor Positive 68 Diabetic Nephropathy 68 Improve Survival 68 Combo Therapy 68 Clinical Outcome 68 JAK Inhibitor 68 Breast Cancer Cells 68 Chemotherapy Improves 68 Reduced Risk 68 Shows Promising 68 IND Application 68 Phase IIb Clinical Trial 68 Immunomodulatory 68 Phase III Trials 68 Epidermal Growth Factor Receptor 68 Efficacy Trial 68 Lowers Risk 68 Clostridium difficile Infection 68 Appears Safe 68 Demonstrates Potential 68 Severe Sepsis 68 Reduces Risk 68 Treated Patients 68 Relapsing Multiple Sclerosis 68 Tumor Growth 68 Gastric Cancer 68 Advanced Renal Cell 68 Study Showed 68 Bone Metastases 68 Solid Tumors 68 Initiates Clinical 68 Interferon Beta 68 Malignant Melanoma 68 Elderly Patients 68 Hepatocellular Carcinoma 67 Preclinical Data 67 Phase 2b Study 67 Phase III Clinical Trial 67 Chemotherapy Induced 67 Hepatitis B Vaccine 67 Protease Inhibitors 67 Oral Mucositis 67 Demonstrates Efficacy 67 Potent Anti 67 Immunosuppressive 67 Treatment Reduces 67 Kinase Inhibitors 67 Venous Thromboembolism 67 Patients Treated 67 Transdermal Patch 67 Tyrosine Kinase Inhibitors 67 Nucleoside 67 Myelodysplastic Syndromes 67 Nicotine Vaccine 67 Hormone Therapy 67 Treatment Resistant 67 Peginterferon 67 Cholesterol Lowering Drug 67 Treatment Regimen 67 Chemoprevention 67 Rotavirus Vaccine 67 Potent Inhibitor 67 Antitumor 67 Inhaled Corticosteroids 67 Study Demonstrates 67 Phase 2a Trial 67 Psoriasis Drug 67 Proves Effective 67 Maribavir 67 Pooled Analysis 67 Hematological Malignancies 67 Epoetin Alfa 67 Fracture Risk 67 Anti Inflammatory 67 Advanced Colorectal Cancer 67 Chronic Hepatitis C 67 Colorectal Cancer Patients 67 Investigational Drug 67 Renal Cancer 67 Gemcitabine 67 Parathyroid Hormone 67 Vaccine Candidate 67 Multiple Myeloma Patients 67 Oral Fingolimod 67 Systemic Delivery 67 HCV Protease Inhibitor 67 Small Molecule 67 Platinol ® 67 Insulin Resistance 67 Soft Tissue Sarcoma 67 Chronic Sinusitis 67 Regimens 67 Granted Orphan Drug 67 Complete Remission 67 Chronic Myeloid Leukemia 67 Presents Preclinical Data 67 Postmenopausal Osteoporosis 67 Localized Prostate Cancer 67 Lymphoid 67 Antiviral Drugs 67 Hypercholesterolemia 67 Serious Infections 67 Initiate Clinical Trial 67 Prophylactic Treatment 67 Fluorouracil 67 Slow Progression 67 Inflammatory Diseases 67 Endometrial Cancer 67 Immunotherapeutic 67 Knee Osteoarthritis 67 Benign Prostatic Hyperplasia 67 Kidney Transplant Recipients 67 Tiotropium 67 Disease Progression 67 Teva Provides Update 67 Erlotinib 67 Files IND 67 Preclinical Models 67 Anticancer Compound 67 Progenitor Cells 67 Diabetic Foot Ulcer 67 Tumor Response 67 Atypical Antipsychotic 67 Progressive Multifocal Leukoencephalopathy 67 Cancer Treatments 67 Valopicitabine 67 Thromboembolism 67 Vaccine Adjuvant 67 Inhibits 66 Treatment Naïve 66 Virus Infection 66 Long Term Efficacy 66 Hypertensive Patients 66 Therapy Improves 66 Enlarged Prostate 66 Antigen Specific 66 Protein Involved 66 Significantly Improves 66 Anticancer Agent 66 Complicated Skin 66 Demonstrates Potent 66 Advanced Ovarian Cancer 66 Breast Cancer Recurrence 66 Invasive Fungal Infections 66 Dasatinib 66 Zoledronic Acid 66 HDAC Inhibitor 66 Study Evaluating 66 Low Dose 66 MEK Inhibitor 66 Relapsed Refractory 66 Inflammatory Disease 66 Cognitive Decline 66 Recombinant Human 66 Hsp# Inhibitor 66 Patients Undergoing 66 Vaccine Protects Against 66 Receptor Antagonists 66 Anti Tumor Activity 66 Achieves Primary Endpoint 66 Advanced Pancreatic Cancer 66 Phase IIa Clinical Trial 66 NDA Submission 66 Bortezomib 66 Combination REOLYSIN R 66 Prostate Cancer Patients 66 Therapeutic Potential 66 Ovarian Cancer Patients 66 Predict Response 66 Thrombotic 66 Topical Treatment 66 See CLINICAL PHARMACOLOGY 66 Drug Resistant 66 Invasive Breast Cancer 66 Reduces Mortality 66 Gout Drug 66 Nilotinib 66 Pegylated Liposomal Doxorubicin 66 Lupus Nephritis 66 Successfully Completes Phase 66 Aliskiren 66 Drug Combo 66 Metastatic Melanoma 66 Novel Mechanism 66 Chronic Hepatitis B 66 Gene Linked 66 Epilepsy Drug 66 Brain Metastases 66 Potent Antiviral Activity 66 Pivotal Phase III 66 5 Fluorouracil 66 Pegylated 66 Clinical Trial Evaluating 66 Atopic Dermatitis 66 Modulates 66 Receptor Agonist 66 FDA Approvals 66 Lung Cancer Survival 66 Hyperlipidemia 66 Drug Prevents 66 Stent Placement 66 Pafuramidine 66 Lenalidomide 66 Capecitabine 66 Anemia Drug 66 Glufosfamide 66 Potentially Fatal 66 Phase III Trial 66 Analytical Tool 66 Statistically Significant 66 Test Detects 66 Nanoemulsion 66 Osteoporosis Treatment 66 Wound Dressings 66 Blood Pressure Drug 66 Levels Linked 66 Liver Injury 66 Statin Drugs 66 Significantly Improved 66 Significantly Reduces 66 Melphalan 65 Neoadjuvant 65 Interferon Alfa 65 Cancer Vaccines 65 Clinical Trial Data 65 Dose Ranging Study 65 Estrogen Receptor 65 Chemotherapy Regimen 65 Osteoarthritis Patients 65 Initiate Phase 65 Replacement Therapy 65 ACE Inhibitors 65 Non Responders 65 Statin Therapy 65 Significantly Reduced 65 Smallpox Vaccine 65 Hematological Cancers 65 Androgen Independent 65 Cell Transplants 65 Erectile Dysfunction Drug 65 Malignant Glioma 65 Septic Shock 65 Initiates Phase III 65 Cisplatin 65 Cardiotoxicity 65 Leukemia Cells 65 Resistant Hypertension 65 Renal Function 65 Angiogenic 65 Breast Cancers 65 Data Suggest 65 Metastatic Cancer 65 Adefovir 65 Metastatic Renal Cell Carcinoma 65 Tezampanel 65 Osteoporosis Drug 65 Anticancer Drugs 65 Anticoagulant 65 Drug Fails 65 Immune Cells 65 Dose Escalation 65 Tumor Necrosis Factor 65 Cancer Cells 65 Postmenopausal Women 65 Higher Doses 65 Phase 2a Clinical Trial 65 Present Preclinical Data 65 Newly Diagnosed 65 Submits NDA 65 Emerging Therapies 65 Unresectable 65 Trial Evaluating 65 Protein Linked 65 Antiplatelet 65 Placebo Controlled Trial 65 Androgen Deprivation Therapy 65 Castration Resistant Prostate Cancer 65 Predict Risk 65 Rheumatoid Arthritis Drug 65 Cardiovascular Disease Risk 65 Paroxysmal Atrial Fibrillation 65 Aurora Kinase 65 Hepatitis C Genotype 65 Minimally Invasive Treatment 65 Voreloxin 65 Metastatic Breast Cancer 65 Antiviral Therapy 65 Lanthanum Carbonate 65 Guidelines Issued 65 Avian Flu Vaccine 65 Fixed Dose 65 Lung Cancers 65 Immunosuppression 65 Novel Vaccine 65 Fewer Side Effects 65 Mimetics 65 Vitro Activity 65 Glatiramer Acetate 65 Skin Lesions 65 Anti Angiogenic 65 RNAi Therapeutics 65 Node Positive 65 Darbepoetin Alfa 65 Shown Effective 65 Myeloma Patients 65 Oligonucleotides 65 Antipsychotic Medications 65 Therapeutic Antibody 65 Gene Mutation 65 Blood Cancers 65 Antithrombin 65 Smooth Muscle 65 TAXOTERE R 65 Versus Placebo 65 Peginterferon Alfa 2a 65 Successfully Treated 65 Critically Ill Patients 65 Beta Blockers 65 Prognostic Value 65 Estrogen Therapy 65 SPRYCEL ® 65 Tissue Engineered 65 Refractory Hodgkin Lymphoma 65 Tigecycline 65 Novel Therapeutic 64 Nymox NX 64 Randomized Study 64 Adenoma 64 Cytarabine 64 Cutaneous T 64 Non Invasive Treatment 64 Patient Enrollment 64 Radical Prostatectomy 64 Immune Therapy 64 Myelodysplastic Syndrome MDS 64 Tumor Progression 64 Daptomycin 64 Treatment Shows Promise 64 Targeted Therapies 64 Inflammatory Arthritis 64 Gastrointestinal Stromal Tumors 64 Breast Cancer Stem Cells 64 Genes Linked 64 Oxaliplatin 64 Plaque Psoriasis 64 Menopausal Symptoms 64 Milestone Payment 64 Chronic Renal Failure 64 Prolongs Life 64 Antiviral Activity 64 Immunosuppressant 64 Interferon Gamma 64 Trastuzumab 64 Nitazoxanide 64 Moxifloxacin 64 Adjunctive 64 Monoclonal Antibodies 64 Vertebral Fractures 64 Recurrent Breast Cancer 64 NICE Recommends 64 Carboplatin Paclitaxel 64 Infected Patients 64 Muscle Wasting 64 Artery Disease 64 Excretion 64 Transdermal Delivery 64 Mouse Models 64 Arthritis Drug 64 Novel Treatments 64 Anticancer Activity 64 Relapsed Multiple Myeloma 64 Asthma COPD 64 Shingles Vaccine 64 Skin Cancers 64 Therapeutic Agents 64 Retreatment 64 Novel Therapies 64 Leukemias 64 Presents Positive 64 Cyclophosphamide 64 Relapsed Refractory Multiple Myeloma 64 Metabolic Disorder 64 Cytotoxicity 64 Hepatitis C Virus 64 Meta Analysis 64 Lymphocytic 64 Presents Preclinical 64 Small Intestine 64 Improve Outcomes 64 Initiates Phase II 64 Boosts Survival 64 Tumor Cell 64 Gum Disease 64 Controlled Trial 64 Chronic Inflammation 64 Randomized Phase 64 Percutaneous Tibial Nerve Stimulation 64 Intravitreal 64 Prove Effective 64 Telaprevir VX 64 Diagnostic Criteria 64 Renal Anemia 64 Attenuates 64 Subtypes 64 Molecular Mechanism 64 Epithelial Ovarian Cancer 64 Kidney Function 64 Peginterferon Alfa 2b 64 Platinol ® cisplatin 64 Novel Compound 64 Antidiabetic 64 Demonstrates Positive 64 Long Term Survival 64 Cholesterol Lowering 64 Alemtuzumab 64 Extended Release 64 FDA Okays 64 Signaling Pathway 64 Pharmacokinetic Study 64 Breast Cancer Treatment 64 Induces 64 Lung Injury 64 Overactive Bladder 64 Epratuzumab 64 Oral Formulation 64 Acute Ischemic Stroke 64 Bisphosphonate 64 Diagnosis Treatment 64 Study Shows Promise 64 Radiofrequency Ablation 64 Myocardial Ischemia 64 Oral Calcitonin 64 Follicular Lymphoma 64 Therapeutic Efficacy 64 Blood Clotting 64 Phase 1b Clinical Trial 64 Treatment Naive Patients 64 Corticosteroid 64 Increased Mortality 64 Radiation Induced 64 Factor Receptor 64 Genes Identified 64 adalimumab Humira 64 Targeted Therapy 64 Irinotecan 64 Cardiovascular Events 64 Genetic Mutation 64 Anti Infective 64 Asthma Treatment 64 Hematopoietic Stem Cells 64 Partial Onset Seizures 64 Diabetic Patients 64 Holds Promise 64 TNF Blockers 64 Lung Cancer Trial 64 Antidepressant Drug 64 Secondary Hyperparathyroidism 64 Chronic Lymphocytic Leukemia 64 Reduces Pain 64 Circulating Tumor Cells 63 5 FU leucovorin 63 Omacetaxine 63 Demonstrated Significant 63 Gene Variant 63 Randomized Trials 63 Chemotherapeutic 63 Hospital Acquired Pneumonia 63 Preclinical Study 63 Anti CD# Antibody 63 Slows Progression 63 Dehydrogenase 63 Confirmatory Phase 63 Sapacitabine 63 Prophylaxis 63 Heart Failure Patients 63 Azacitidine 63 Cannabinoid 63 GW# [003] 63 Prodrug 63 Prospective Randomized 63 Intravesical 63 Breast Tumors 63 FDA Accepts 63 Plus Ribavirin 63 Cognitive Impairment 63 Natalizumab 63 Nerve Regeneration 63 Oral Cavity 63 investigational oral inhibitor 63 Prostate Cancers 63 Hormonal Therapy 63 Naturally Occurring 63 Tablet Formulation 63 Angiotensin Converting Enzyme 63 Thyroid Hormone 63 Investigational Oral 63 Fibroblast 63 Cyclooxygenase 2 63 Recurrent Prostate Cancer 63 Effectively Treats 63 Neoplasms 63 Demonstrates Sustained 63 Deforolimus 63 Tumor Cells 63 Novel Inhibitor 63 Poster Presentations 63 Pertuzumab 63 Peripheral Blood 63 Bioavailability 63 Stakeholder Opinions 63 Gastrointestinal Disorders 63 Ovarian Cancers 63 Demonstrates Statistically Significant 63 Receives Fast Track 63 Pediatric Patients 63 Carboplatin 63 Cardiovascular Outcomes 63 Adjuvant Breast Cancer 63 P#Y# [001] 63 Immunogenic 63 Blood Pressure Lowering 63 Cocaine Addiction 63 Premature Infants 63 Decitabine 63 Mg Usa 63 Immune Mediated 63 II Clinical Trial 63 Fluconazole 63 Combination Clinical Trial 63 Randomized Double Blind 63 Synthetic Peptide 63 Experimental Vaccine 63 Vidaza azacitidine 63 Bosutinib 63 Schizophrenia Treatment 63 Antibacterials 63 Drug Regimen 63 Lyophilized 63 Squamous 63 Therapeutic Antibodies 63 Neural Stem Cells 63 Apaziquone 63 ergot derivatives 63 Gemzar ® 63 Monoclonal 63 Crit Rev 63 First Patient Dosed 63 Colorectal Adenomas 63 Fibrinogen 63 FDA Warns Against 63 Breast Cancer Patients 63 Being Studied 63 Neovascular Age Related Macular 63 Renal Tumors 63 Double Blind Randomized 63 Signaling Pathways 63 Aflibercept 63 Study Shows Benefits 63 Treatment Experienced 63 Autoimmune Diseases 63 Oncolytic 63 Nebulized 63 Brentuximab Vedotin SGN 63 Fulvestrant 63 Neuroprotective Effects 63 Placebo Controlled Study 63 Naive Patients 63 Inflammatory Response 63 MGd 63 Cholesterol Drugs 63 Files Investigational 63 Ridaforolimus 63 topoisomerase II inhibitor 63 Efficacious 63 Viral Suppression 63 Oxidative Stress 63 Antipsychotic 63 Osteoporosis Drugs 63 Selective Internal 63 Schizophrenia Drug 63 paclitaxel Taxol R 63 Fludarabine 63 Elotuzumab 63 Randomized Phase II 63 Genetic Tests 63 Malignant Pleural Mesothelioma 63 Hepatitis C Patients 63 Anti TNF 63 FDA Approves Drug 63 Dose Response 63 Isavuconazole 63 Camptosar ® 63 Showed Significant 63 Hepatic Encephalopathy 63 Universal Flu Vaccine 63 Genentech Provides Update 63 Molecular Diagnostic Test 63 Presents Positive Preclinical 63 Desvenlafaxine Succinate 63 Conjugate 63 Cellular Immunotherapy 63 Stomach Cancer 63 lexidronam injection 63 Inhaled Insulin 63 Dry Powder Inhalers 63 Begins Dosing 63 Entry Inhibitor 63 Autoimmune Disorders 63 ARRY # 63 FDA Clears 63 Viral Load 63 ST Elevation Myocardial 63 Radioimmunotherapy 63 Vaccine Adjuvants 63 Mucosal 63 Blocked Arteries 63 Enzyme Replacement Therapy 63 abacavir Ziagen 63 Pivotal Study 63 Pregnancy Linked 63 Systematic Review 63 Pharmacokinetics PK 63 Paraplatin ® carboplatin 63 NSABP B 63 Initiates Enrollment 62 Controlled Study 62 Drug Resistant Bacteria 62 Mitoxantrone 62 Temsirolimus 62 Endovascular Treatment 62 Vaccine Shows Promise 62 Coronary Arteries 62 Wound Dressing 62 Idiopathic Pulmonary Fibrosis 62 Pre Cancerous 62 Effective Treatments 62 Receives Milestone Payment 62 Tolerability 62 Macrolide 62 Initiates Clinical Trials 62 Improves Quality 62 Immunologic 62 Treatment Naive 62 Increases Risk 62 Obesity Linked 62 Prostate Tumors 62 Commence Phase 62 ThermoDox R 62 Sevelamer 62 Oral Spray 62 Myelofibrosis 62 gefitinib Iressa 62 Antibody Drug Conjugate 62 Relapsing Remitting Multiple Sclerosis 62 Anti Inflammatory Drug 62 Impairs 62 PRN FDA Approves 62 Granulocyte Colony Stimulating Factor 62 sorafenib Nexavar 62 Study Casts Doubt 62 Proteasome 62 ZOLINZA 62 Autologous Stem Cell Transplantation 62 Commercialize Novel 62 Begin Clinical Trials 62 Sipuleucel T 62 Visceral Fat 62 Patients Suffering 62 Ibritumomab Tiuxetan 62 Liver Metastases 62 Golimumab 62 Clinical Outcomes 62 tiuxetan 62 Beneficial Effects 62 Genes Predict 62 Skin Disorders 62 Cervical Dysplasia 62 Premature Aging 62 Pazopanib 62 Hepatocellular 62 Increased Risk 62 Cholesterol Drug 62 Pivotal Trial 62 Colorectal Cancers 62 Phase III Pivotal 62 Drug Formulation 62 DNA Methylation 62 Diabetic Macular Edema 62 Protein Interactions 62 Azathioprine 62 J Clin 62 Boceprevir 62 Posaconazole 62 Parenteral Nutrition 62 JAK2 Inhibitor 62 BARACLUDE R 62 Commences Phase 62 Demonstrate Significant 62 Aptamer 62 Shows Statistically Significant 62 Brain Atrophy 62 alkylating agent 62 Neulasta ® 62 Radiofrequency Ablation RFA 62 Glucocorticoid 62 Recurrent Ovarian Cancer 62 Sleep Disturbances 62 Completes Enrollment 62 Therapeutic Vaccine 62 Abiraterone Acetate 62 Biomarker Study 62 Diffuse Large B 62 Topotecan 62 Adult Stem Cell Therapy 62 erlotinib Tarceva ® 62 paclitaxel Taxol ® 62 Symptom Relief 62 Randomized Double blind 62 Diuretic 62 Pandemic Flu Vaccine 62 Antiviral Agents 62 Apoptotic 62 Alternative Treatments 62 Long Term Outcomes 62 Cethromycin 62 Hedgehog Pathway 62 Randomized Controlled Trials 62 Relapsed 62 Respiratory Virus 62 Tuberculosis Vaccine 62 Docetaxel 62 Pivotal Clinical Trial 62 Gene Mutations 62 Initiates Phase 2b 62 Initiates Phase 62 Basal Cell 62 AnaSpec Introduces 62 Erythropoietic 62 Cell Proliferation 62 cisplatin carboplatin 62 essential thrombocythemia ET 62 Novel Method 62 Node Negative 62 Retinal Vein Occlusion 62 Vitrasert R 62 Ebola Vaccine 62 Degarelix 62 Catheter Associated 62 Curable 62 Vidaza ® 62 Cloretazine ® 62 Stem Cell Transplants 62 Platelet Inhibition 62 Prognostic Significance 62 Malignancies 62 Adjuvant 62 metastatic malignant 62 Migraine Drug 62 Sustained Reduction 62 Interferon Alpha 62 Etanercept 62 Antipsychotic Drug 62 Cinacalcet 62 MAGE A3 ASCI 62 Chronic Liver Disease 62 Receives Approvable Letter 62 Sinus Infections 62 Conjugated 62 Migraine Treatment 62 DOXIL 62 Viral Infections 62 Protein Expression 62 Trabectedin 62 LENALIDOMIDE 62 Genes Associated 62 monoclonal antibody conjugated 62 Brain Tumor Therapy 62 Subgroup Analysis 62 Renal Cell Cancer 62 Epilepsy Drugs 62 Kidney Failure 62 Phase Ib Clinical Trial 62 Neuroprotective 62 Collaborators Publish 62 Medullary Thyroid Cancer 62 Periodontal Disease 61 Lowers Blood Pressure 61 Pivotal Phase 61 Antiepileptic Drug 61 Cholesterol Levels 61 Protein Biomarker 61 PROSTASCINT R 61 Novel Small Molecule 61 Montelukast 61 Help Detect 61 Multidrug Resistant 61 Hematopoietic 61 Ischemic 61 Laryngeal Cancer 61 Polymerase Inhibitor 61 Antisense Drug 61 Anticancer Agents 61 Corneal Transplant 61 Initiate Phase III 61 Breast Tumor 61 Prostate Cancer Treatment 61 Preclinical Evaluation 61 Gene Variation 61 Liver Failure 61 thalidomide Thalomid 61 Advanced Gastric Cancer 61 Immunomedics Announces 61 Kidney Transplant Patients 61 Often Misdiagnosed 61 FASLODEX 61 microtubule inhibitor 61 Prostate Cancer Survival 61 Squamous Cell Carcinoma 61 Reperfusion Injury 61 Intravascular 61 Pharmacologic Treatment 61 FDA Clearance 61 Stable Coronary Artery 61 Breast Cancer Metastasis 61 Clinical Trial Enrollment 61 Pneumococcal Vaccine 61 Daclizumab 61 Ecallantide 61 Newly Diagnosed Patients 61 Immune Cell 61 Pralatrexate 61 Structure Function 61 Malaria Vaccine 61 Acute Migraine 61 Transthyretin 61 Liver Toxicity 61 Antibiotic Treatment 61 Embolization 61 Progenitor Cell 61 carmustine 61 Abciximab 61 alfa 2a 61 Cognitive Deficits 61 Tumor Suppressor Gene 61 Paclitaxel Carboplatin 61 antineoplastic 61 Sirolimus Eluting Stent 61 Bone Marrow Stem Cells 61 Multicenter Randomized 61 Protein Synthesis 61 Iron Deficiency 61 Fabry Disease 61 Shows Promise 61 novel emulsion formulation 61 Collaborators Present 61 Pivotal Trials 61 ORLive Presents 61 docetaxel Taxotere ® 61 Aggressive Prostate Cancer 61 EGFR TKI 61 Cloretazine 61 Ranolazine 61 Clinical Efficacy 61 Preterm Delivery 61 Earns Milestone Payment 61 Renal Impairment 61 Reductase 61 Prostatic 61 Microspheres 61 Epithelial 61 Dose Finding 61 Therapeutic Monoclonal Antibodies 61 Uterine Cancer 61 Proton Pump Inhibitors 61 Study Proves 61 Breast Tissue 61 Minimally Invasive Procedure 61 Anti VEGF 61 Osteoarthritis Pain 61 Differential Diagnosis 61 Prognostic Factors 61 Ultrasensitive 61 Antifungals 61 Hepatitis C Virus HCV 61 Febrile Neutropenia 61 Antibiotic Resistant 61 Milestone Payments 61 Sustained Release 61 Liposomal 61 Genetic Markers 61 Cancer Immunotherapy 61 Omalizumab 61 Urinary Incontinence 61 Inhaled Liposomal Ciprofloxacin 61 PSMA ADC 61 Severe Asthma 61 Cancer Therapies 61 Romidepsin 61 paclitaxel Taxol 61 Bladder Cancer 61 Bronchodilator 61 Maleate 61 #-# Full Text 61 Receives Orphan Drug 61 Could Prevent 61 Can Predict